Profile data is unavailable for this security.
About the company
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
- Revenue in USD (TTM)1.01bn
- Net income in USD-204.71m
- Incorporated2008
- Employees2.50k
- LocationTandem Diabetes Care Inc12400 High Bluff DriveSAN DIEGO 92130United StatesUSA
- Phone+1 (858) 366-6900
- Fax+1 (302) 636-5454
- Websitehttps://www.tandemdiabetes.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adapthealth Corp | 3.24bn | -70.27m | 1.28bn | 10.90k | -- | 0.8385 | 3.86 | 0.3937 | -0.5224 | -0.5224 | 23.84 | 11.21 | 0.7372 | 17.60 | 8.33 | 297,693.30 | -1.50 | -1.84 | -1.76 | -2.08 | 21.07 | 20.27 | -2.04 | -2.74 | 0.8109 | 1.96 | 0.5393 | -- | -0.4943 | 25.16 | -185.55 | -- | 57.26 | -- |
| Iradimed Corp | 83.81m | 22.48m | 1.33bn | 160.00 | 59.62 | 14.02 | 78.86 | 15.83 | 1.75 | 1.75 | 6.52 | 7.44 | 0.8094 | -- | -- | -- | 21.71 | 18.06 | 23.86 | 20.21 | 76.75 | 76.85 | 26.82 | 25.51 | -- | -- | -- | -- | 14.43 | 21.45 | 16.88 | 108.61 | -- | -- |
| Kestra Medical Technologies Ltd | 74.26m | -138.79m | 1.34bn | 330.00 | -- | 7.19 | -- | 18.01 | -2.76 | -2.76 | 1.47 | 3.19 | 0.4034 | -- | 9.40 | 225,027.30 | -71.43 | -122.23 | -92.37 | -192.35 | 46.40 | -- | -177.06 | -342.51 | -- | -116.72 | 0.2033 | -- | 115.05 | -- | -25.08 | -- | 150.61 | -- |
| Conmed Corp | 1.37bn | 47.06m | 1.34bn | 3.90k | 28.69 | 1.30 | 11.03 | 0.9736 | 1.51 | 1.51 | 44.20 | 33.36 | 0.5936 | 1.78 | 5.66 | 352,493.60 | 2.03 | 2.11 | 2.33 | 2.41 | 54.59 | 54.98 | 3.42 | 3.78 | 1.01 | 3.30 | 0.447 | 51.06 | 5.18 | 9.77 | -64.47 | 37.66 | 8.76 | -5.59 |
| Enovis Corp | 2.25bn | -1.18bn | 1.45bn | 7.80k | -- | 0.971 | -- | 0.644 | -20.69 | -20.72 | 39.39 | 26.05 | 0.5256 | 1.66 | 5.29 | 288,137.50 | -27.63 | -7.98 | -31.84 | -9.05 | 58.16 | 56.87 | -52.57 | -24.34 | 1.04 | 1.06 | 0.465 | -- | 6.66 | -6.05 | -42.80 | -- | 11.45 | -- |
| Quidelortho Corp | 2.73bn | -1.13bn | 1.46bn | 6.50k | -- | 0.7594 | -- | 0.5356 | -16.66 | -16.66 | 40.25 | 28.28 | 0.4478 | 2.62 | 7.12 | 420,030.80 | -18.56 | -6.45 | -22.13 | -7.39 | 46.67 | 53.89 | -41.45 | -14.40 | 0.9002 | 0.3677 | 0.5798 | -- | -1.89 | 10.44 | 44.84 | -- | 23.72 | -- |
| Procept Biorobotics Corp | 308.05m | -95.57m | 1.48bn | 888.00 | -- | 4.04 | -- | 4.81 | -1.72 | -1.72 | 5.55 | 6.50 | 0.5912 | 1.76 | 3.69 | 346,907.70 | -18.34 | -23.13 | -20.70 | -25.70 | 63.70 | 58.76 | -31.02 | -56.52 | 5.77 | -- | 0.1236 | -- | 37.22 | 109.04 | -4.55 | -- | 109.29 | -- |
| Novocure Ltd | 655.35m | -136.23m | 1.51bn | 1.61k | -- | 4.39 | -- | 2.31 | -1.22 | -1.22 | 5.88 | 3.03 | 0.6409 | 4.35 | 8.01 | 408,319.60 | -13.32 | -11.74 | -25.57 | -15.63 | 74.73 | 76.71 | -20.79 | -23.31 | 2.71 | -- | 0.3642 | -- | 8.28 | 5.80 | 19.21 | -- | 12.23 | -- |
| AxoGen Inc | 225.21m | -15.70m | 1.55bn | 622.00 | -- | 10.93 | -- | 6.87 | -0.3413 | -0.3413 | 4.77 | 2.73 | 1.06 | 1.53 | 8.96 | 362,070.80 | -7.38 | -10.17 | -8.46 | -11.70 | 74.31 | 77.27 | -6.97 | -12.34 | 3.31 | -0.9786 | 0.2732 | -- | 20.21 | 14.93 | -57.60 | -- | -24.36 | -- |
| UFP Technologies Inc | 602.80m | 68.31m | 1.57bn | 4.85k | 23.17 | 3.69 | 17.88 | 2.60 | 8.76 | 8.76 | 77.29 | 54.95 | 0.9389 | 4.96 | 7.19 | 124,390.60 | 10.64 | 10.57 | 12.06 | 12.07 | 28.27 | 27.60 | 11.33 | 11.12 | 1.52 | 9.46 | 0.2422 | 0.00 | 19.50 | 27.43 | 15.82 | 38.57 | 24.23 | -- |
| AtriCure Inc | 534.53m | -11.45m | 1.57bn | 1.35k | -- | 3.18 | 172.52 | 2.93 | -0.241 | -0.241 | 11.19 | 9.88 | 0.8461 | 1.74 | 8.42 | 395,946.70 | -1.81 | -2.67 | -2.07 | -2.98 | 74.98 | 74.88 | -2.14 | -4.13 | 2.99 | -6.75 | 0.1232 | -- | 14.88 | 20.95 | 74.39 | -- | 23.40 | -- |
| Tandem Diabetes Care Inc | 1.01bn | -204.71m | 1.62bn | 2.50k | -- | 10.45 | -- | 1.60 | -3.07 | -3.07 | 15.08 | 2.27 | 1.10 | 3.37 | 7.25 | 405,894.40 | -22.15 | -12.88 | -30.13 | -16.00 | 53.81 | 52.12 | -20.17 | -14.32 | 2.02 | -6.00 | 0.6699 | -- | 7.93 | 15.26 | -113.18 | -- | -9.19 | -- |
| Artivion Inc | 441.33m | 9.76m | 1.85bn | 1.80k | 194.39 | 4.12 | 57.38 | 4.19 | 0.1987 | 0.1987 | 9.44 | 9.37 | 0.5273 | 1.82 | 5.22 | 245,183.30 | 1.17 | -1.72 | 1.30 | -1.86 | 64.40 | 64.69 | 2.21 | -3.80 | 2.62 | 1.44 | 0.3278 | -- | 13.59 | 11.75 | 173.17 | -- | 39.74 | -- |
| Omnicell Inc | 1.18bn | 2.05m | 1.85bn | 3.58k | 944.01 | 1.49 | 22.64 | 1.56 | 0.0432 | 0.0432 | 25.70 | 27.36 | 0.5786 | 7.19 | 5.01 | 330,962.30 | 0.1002 | 0.7331 | 0.1357 | 0.9767 | 42.49 | 44.88 | 0.1732 | 1.32 | 1.22 | -- | 0.1198 | 0.00 | 6.53 | 5.84 | -83.62 | -42.34 | 1.93 | -- |
| Inspire Medical Systems Inc | 911.98m | 145.42m | 1.88bn | 1.33k | 13.24 | 2.41 | 11.80 | 2.06 | 4.97 | 4.97 | 30.75 | 27.33 | 1.06 | 1.18 | 8.57 | 684,156.80 | 16.95 | 3.09 | 19.00 | 3.48 | 85.39 | 84.83 | 15.95 | 3.05 | 4.56 | -- | 0.00 | 0.00 | 13.60 | 51.21 | 171.77 | -- | 73.41 | -- |
| Alphatec Holdings Inc | 764.16m | -143.36m | 1.97bn | 913.00 | -- | 157.44 | -- | 2.58 | -0.9598 | -0.9598 | 5.09 | 0.2398 | 0.9754 | 1.35 | 7.86 | 836,971.50 | -18.30 | -24.58 | -24.00 | -31.32 | 69.60 | 67.58 | -18.76 | -32.07 | 1.28 | -1.28 | 0.9402 | -- | 24.95 | 39.46 | 11.57 | -- | 16.50 | -- |
Data as of Mar 04 2026. Currency figures normalised to Tandem Diabetes Care Inc's reporting currency: US Dollar USD
55.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 9.81m | 14.51% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 6.78m | 10.03% |
| Sessa Capital IM LPas of 31 Dec 2025 | 5.00m | 7.40% |
| ArrowMark Colorado Holdings LLCas of 31 Dec 2025 | 2.89m | 4.28% |
| GW&K Investment Management LLCas of 31 Dec 2025 | 2.68m | 3.96% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 2.64m | 3.91% |
| Paradice Investment Management LLCas of 31 Dec 2025 | 2.08m | 3.08% |
| Citadel Advisors LLCas of 31 Dec 2025 | 2.05m | 3.03% |
| Jennison Associates LLCas of 31 Dec 2025 | 2.02m | 2.99% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 1.87m | 2.76% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
